Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 11, 2011, Pages 731-737

  Mahmoudi, A ^a   Sellier, N ^a   Reboul Marty, J ^b   Chales G ^c   Lalatonne, Y ^d   Bourcier, V ^a   Grando, V ^a   Barget, N ^a   Beaugrand, M ^a   Trinchet, J C ^a   Ganne Carrie N ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PROSPECTIVE STUDY; UNIVARIATE ANALYSIS; VIRAL COMPENSATED CIRRHOSIS;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 83155180491     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.07.009     Document Type: Article

References (24)

1. Kanis J.A., Burlet N., Cooper C., Reginster J., Borgstrom F., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008, 19:399-428.
2. Gonzalez-Calvin J.L., Gallego-Rojo F., Fernandez-Perez R., Casado-Caballero F., Ruiz-Escolano E., Olivares E.G., et al. Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 2004, 89:4325-4330.
3. Chen C.C., Wang S.S., Jeng F.S. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?. J Gastroenterol Hepatol 1996, 11:417-421.
4. Garcia-Valdecasas-Campelo E., Gonzalez-Reimers E., Santolaria-Fernandez F., De la Vega-Prieto M.J., Milena-Abril A., Sanchez-Perez M.J., et al. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol 2006, 41:261-266.
5. Collier J. Bone disorders in chronic liver disease. Hepatology 2007, 46:1271-1278.
6. Leslie W.D., Bernstein C.N., Leboff M.S. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003, 125:941-966.
7. Menon K., Angulo P., Weston S., et al. Bone disease in primary bilary cirrhosis: independent indicators and rate of progression. J Hepatol 2001, 35:316-323.
8. Bonkovsky H.L., Hawkins M., Steinberg K., Hersh T., Galambos J.T., Henderson J.M., et al. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990, 12:273-280.
9. Corazza G.R., Trevisani F., Di Stefano M., De Notaris S., Veneto G., Cecchetti L., et al. Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 2000, 45:1392-1399.
10. Crawford B.A., Kam C., Donaghy A.J., et al. The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 2003, 14:987-994.
11. Gallego-Rojo F.J., Gonzalez-Calvin J.L., Munoz-Torres M., Mundi J.L., Fernandez-Perez R., Rodrigo-Moreno D., et al. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998, 28:695-699.
12. Masaki K., Shiomi S., Kuroki T., Tanaka T., Monna T., Ochi H. Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver. J Gastroenterol 1998, 33:236-240.
13. Monegal A., Navasa M., Guanabens N., et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997, 60:148-154.
14. Gonzales Calvin J., Garcia-Sanchez A., Bellot V., Munoz-Gomez J., Raya-Alvarez E., Salvatierra-Rios D. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol 1993, 28:571-579.
15. Schiefke I., Fach A., Wiedmann M., Aretin A.V., Schenker E., Borte G., et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005, 11:1843-1847.
16. Kanis J.A., Melton L.J., Christiansen C., Johnston C.C., Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
17. Pares A., Guanabens N. Treatment of bone disorders in liver disease. J Hepatol 2006, 45:445-453.
18. O'Gradaigh D., Debiram I., Love S., Johnston C.C., Khaltaev N., et al. A prospective study of discordance in diagnosis of osteoporosis using spine and proximal femur bone densitometry. Osteoporos Int 2003, 14:13-18.
19. Guggenbuhl P., Deugnier Y., Boisdet J.F., et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 2005, 16:1809-1814.
20. Valenti L., Varenna M., Fracanzani A.L., Rossi V., Fargion S., Sinigaglia L., et al. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 2009, 20:549-555.
21. Collier J.D., Ninkovic M., Compston J.E. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002, 1(50):1-9.
22. American Gastroenterological Association American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology 2003, 125:937-940.
23. Recommandations professionnelles: surveillance des malades atteints de cirrhose non compliquée et prévention primaire des complications. Haute Autorité de santé; sep 2007.
24. Lespesailles E., Cotté F.E., Roux C., et al. Prevalence and features of osteoporosis in the French general population. Joint Bone Spine 2009, 76:394-400.